Peer-Reviewed Publication
JACC Cardiovasc Interv2023;16(20):2479-2497.October 23, 2023Journal Article
Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular Interventions.
Saurabhi Samant1, Jules Joel Bakhos1, Wei Wu1, Shijia Zhao1, Ghassan S Kassab2, Behram Khan1, Anastasios Panagopoulos1, Janaki Makadia1, Usama M Oguz1, Akshat Banga1, Muhammad Fayaz1, William Glass3, Claudio Chiastra4, Francesco Burzotta5, John F LaDisa6, Paul Iaizzo7, Yoshinobu Murasato8, Gabriele Dubini9, Francesco Migliavacca9, Timothy Mickley10, Andrew Bicek10, Jason Fontana11, Nick E J West12, Peter Mortier13, Pamela J Boyers3, Jeffrey P Gold3, Daniel R Anderson14, James E Tcheng15, John R Windle14, Habib Samady16, Farouc A Jaffer17, Nihar R Desai18, Alexandra Lansky18, Carlos Mena-Hurtado18, Dawn Abbott19, Emmanouil S Brilakis20, Jens Flensted Lassen21, Yves Louvard22, Goran Stankovic23, Patrick W Serruys24, Eric Velazquez18, Pierre Elias25, Deepak L Bhatt26, George Dangas26, Yiannis S Chatzizisis27
1Center for Digital Cardiovascular Innovations, Division of Cardiovascular Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA; Cardiovascular Biology and Biomechanics Laboratory (CBBL), Cardiovascular Division, University of Nebraska Medical Center, Omaha, Nebraska, USA.
2California Medical Innovations Institute, San Diego, California, USA.
3Interprofessional Experiential Center for Enduring Learning, University of Nebraska Medical Center, Omaha, Nebraska, USA.
4PoliTo(BIO)Med Lab, Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
5Department of Cardiovascular Sciences, Università Cattolica Del Sacro Cuore, Rome, Italy.
6Departments of Biomedical Engineering and Pediatrics - Division of Cardiology, Herma Heart Institute, Children's Wisconsin and the Medical College of Wisconsin, and the MARquette Visualization Lab, Marquette University, Milwaukee, Wisconsin, USA.
7Visible Heart Laboratories, Department of Surgery, University of Minnesota, Minnesota, USA.
8Department of Cardiology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
9Department of Chemistry, Materials and Chemical Engineering 'Giulio Natta', Politecnico di Milano, Milan, Italy.
10Boston Scientific Inc, Marlborough, Massachusetts, USA.
11Medtronic, Inc, Minneapolis, Minnesota, USA.
12Abbott Vascular, Santa Clara, California, USA.
13FEops, Ghent, Belgium.
14Cardiovascular Biology and Biomechanics Laboratory (CBBL), Cardiovascular Division, University of Nebraska Medical Center, Omaha, Nebraska, USA.
15Cardiovascular Division, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA.
16Georgia Heart Institute, Gainesville, Georgia, USA.
17Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
18Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
19Cardiovascular Institute, Warren Alpert Medical School at Brown University, Providence, Rhode Island, USA.
20Center for Advanced Coronary Interventions, Minneapolis Heart Institute, Minneapolis, Minnesota, USA.
21Department of Cardiology B, Odense University Hospital, Odense, Syddanmark, Denmark.
22Institut Cardiovasculaire Paris Sud, Massy, France.
23Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia.
24Department of Cardiology, National University of Ireland, Galway, Galway, Ireland.
25Seymour, Paul, and Gloria Milstein Division of Cardiology, Columbia University Irving Medical Center, NewYork-Presbyterian Hospital, New York, New York, USA.
26Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
27Center for Digital Cardiovascular Innovations, Division of Cardiovascular Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA; Cardiovascular Biology and Biomechanics Laboratory (CBBL), Cardiovascular Division, University of Nebraska Medical Center, Omaha, Nebraska, USA. Electronic address: ychatzizisis@icloud.com.
Abstract
Artificial intelligence, computational simulations, and extended reality, among other 21st century computational technologies, are changing the health care system. To collectively highlight the most recent advances and benefits of artificial intelligence, computational simulations, and extended reality in cardiovascular therapies, we coined the abbreviation AISER. The review particularly focuses o…
Create a free account to keep reading
Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.
Want unlimited research access? See Pro plans